NBLY — Neighbourly Pharmacy Income Statement
0.000.00%
Last trade - 00:00- CA$839.05m
- CA$1.17bn
- CA$749.15m
- 66
- 56
- 68
- 68
Annual income statement for Neighbourly Pharmacy, fiscal year end - March 25th, CAD millions except per share, conversion factor applied.
2019 March 30th | 2020 March 28th | 2021 March 27th | 2022 March 26th | 2023 March 25th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 150 | 187 | 306 | 428 | 749 |
| Cost of Revenue | |||||
| Gross Profit | 62.8 | 72.3 | 115 | 158 | 293 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 154 | 184 | 298 | 428 | 746 |
| Operating Profit | -4.07 | 3.12 | 8.48 | -0.851 | 3.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -24 | -22.9 | -87.9 | -78.4 | -19.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.8 | -23.3 | -90.5 | -72.4 | -14.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -22.8 | -23.3 | -91.3 | -73.4 | -15.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -22.8 | -23.3 | -91.3 | -73.4 | -15.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.57 | -0.618 | -18.8 | -2.19 | -0.201 |
| Dividends per Share |